Search results
Moderna scores European victory over Pfizer and BioNTech in mRNA patent battle
Endpoints News· 4 days agoThe European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with...
A boost for HIV vaccine research: Studies present comprehensive platform for validating next steps
Medical Xpress· 5 hours agoA substantial amount of research has demonstrated the feasibility of the initial activation step; now, in two papers simultaneously out in Science and Science Immunology, researchers at the ...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 days agoThe review is now expected to be completed by the end of this month. The FDA, however, did not...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Benzinga via Yahoo Finance· 5 hours agoAlso Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Benzinga· 5 hours agoAlso Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 6 hours agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 5 days agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Iran's new president's link to COVID vaccine
Newsweek· 1 day agoNew interim Iranian President Mohammad Mokhber received scrutiny for his role in the lack of development of a domestic vaccine at the height of the...
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoNBC Securities Inc. grew its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent 13F filing ...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 days agoToday, Pfizer and Moderna dominate the coronavirus vaccine market, making it difficult for a smaller player to gain much share, but an alliance with a...